fbpx

Tag Archives | science

Dr. William Z. Levine, Founder and Chief Scientific Officer

Dr. Bill Levine, Founder and Chief Scientific Officer of CannRx, a biotech company that develops proprietary, scientifically based medical and recreational cannabis products that have consistent therapeutic effects.

Dr. Levine is a highly sought-out speaker and resource for the cannabis industry. He was most recently named Cannabis & Tech Today’s Innovator of the Year for 2019 and is one of the primary drivers of the Israeli cannabis marketplace. Our hosts will chat with Dr. Levine about his extensive background in botanical medicine and how that has aided him in his transition to the cannabis space. In addition, we will discuss Israel’s rise as a hub for technological and medical innovation and how his company CannRx is working on finding water soluble, bioavailable solutions to disrupt the cannabis beverage space.

Dr. Levine is an incredible source of information and if you have any interest in the science and technology driving the future of the cannabis industry you will love this episode.

Don’t sit back, lean forward and enjoy!

Dr. William Z. Levine, Founder and Chief Scientific Officer

Dr. Bill Levine is the founder of Izun Pharmaceuticals Corporation, a biopharmaceutical company specializing in Botanical Medicine. This area of specialty pharma develops pharmaceutical and healthcare products from plant-based sources. Bill, who received his DDS degree and specialty training in Periodontics from Columbia University, initially utilized this background to formulate novel oral care products to treat periodontal disease more effectively. Izun has also developed wound care products, oncology support products, and products targeting women’s health care.

Recognizing the Izun expertise with botanicals, Bill subsequently applied this knowledge to the cannabis plant and established CannRx. In a short time, CannRx has developed validated assays (receiving ISO 17025 service laboratory certification) and new and differentiated delivery systems. CannRx has identified & licensed new potent strains and appears well on its way to establishing itself as a leading player in the cannabis field.

Links and mentions:

Links to guest’s social media:

Show Credits:

This episode was hosted by Lewis Goldberg and Anne Donohoe of KCSA Strategic Communications.

Special thanks to our Executive Producer Nick Opich and Program Director Shea Gunther at Marijuana Today

You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:

Twitter: @The_GreenRush 

Instagram: @thegreenrush_podcast

LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/ 

Facebook: https://www.facebook.com/TheGreenRushPodcast/ 

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Dr. Rick Strassman, Clinical Associate Professor of Psychiatry at the University of New Mexico School of Medicine

Dr. Rick Strassman, Clinical Associate Professor of Psychiatry at the University of New Mexico School of Medicine, is this week’s guest on The Green Rush!

After twenty years of intermission, Dr. Strassman was the first person in the United States to undertake human research with psychedelic, hallucinogenic, or entheogenic substances with his research in the 1990s. Thanks to the research by Dr. Strassman, organizations like the Multidisciplinary Association of Psychedelic Studies (MAPS) have moved the ball forward with the FDA to the point that MDMA – or ecstasy – has been granted Phase III breakthrough status for the treatment of PTSD and universities such as NYU, the Imperial College in London and Johns Hopkins are all conducting cutting edge research.

For this episode, Lewis dives deep with Dr. Strassman about the medical value of psychedelics, how he reflects on his research 20 years after the fact what he foresees as the future of psychedelic medicine. Anyone following the cannabis industry should be closely following the psychedelics space as the paths to legalization for both are nearly parallel. 

Don’t sit back, lean forward and enjoy!

About Dr. Rick Strassman

Los Angeles native, Rick Strassman, holds degrees from Stanford University and Albert Einstein College of Medicine of Yeshiva University. He took his internship and general psychiatry residency at the University of California, Davis, Medical Center in Sacramento and he spent ten years as a tenured professor at the University of Mexico. Dr. Strassman also began the first new U.S.-Government-approved-and funded clinical research with psychedelic drugs in over twenty years. In addition, he has been a consultant to the U.S. Food and Drug Administration, National Institute on Drug Abuse, Veteran’s Administration Hospitals, Social Security Administration, and other state and local agencies. Dr. Strassman currently practices psychiatry in Taos, New Mexico and is Clinical Associate Professor of Psychiatry in the UNM School of Medicine.While living in the Pacific Northwest of the United States for five years, Dr. Strassman worked in community mental health centers for Washington State’s Whatcom and Jefferson Counties. He currently lives and practices psychiatry in Taos, New Mexico, and is Clinical Associate Professor of Psychiatry at the University of New Mexico School of Medicine.

Links to guest’s social media:

Links and Mentions:

Show Credits:

This episode was hosted by Lewis Goldberg and Anne Donohoe of KCSA Strategic Communications.

Special thanks to our Executive Producer Nick Opich Program Director Shea Gunther at Marijuana Today

You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:

Twitter: @The_GreenRush 

Instagram: @thegreenrush_podcast

LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/ 

Facebook: https://www.facebook.com/TheGreenRushPodcast/ 

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Congressional Cannabis Day Part 3 – Opioids, Is Cannabis the Answer? Panel

We’re onto part three of our special series highlighting the panels of the inaugural “KCSA Congressional Cannabis Day Forum” at the U.S. Capitol in Washington, D.C. As part of the event, KCSA gathered a host of some of the brightest minds in the industry for a series of panel discussions aimed at addressing critical issues relevant to the sector, including capital markets and banking, CBD/hemp, opioids, veterans’ issues and social justice.

In the third installment of this four part series, we hear from our Opioids, Is Cannabis the Answer? Panel. We were privileged to have with us, Dr. Bonni Goldstein, Medical Director of Canna-Centers Wellness and Education Dr. Richard Boxer, Clinical Professor of Urology at the David Geffen School of Medicine at UCLA, Dr. Patricia Frye, Chief Medical Officer of HelloMD, and Moderator Carl Cameron, formerly of Fox News Channel.

So often the medicinal benefits and the real impact cannabis has as an alternative to opioids can be forgotten so it was great to have some of the foremost researchers on this topic speak to the tremendous value cannabis brings to those in need. What follows is a conversation that explores how cannabis affects our bodies, what benefits and treatments researchers have been able to garner from limited research to date and what next steps are needed to expand clinical research on the plant.

So don’t sit back, lean forward and enjoy!

Links to guest’s social media:

Links and Mentions:

Show Credits:

This episode was hosted by Lewis Goldberg and Gretchen Gailey of KCSA Strategic Communications.

Special thanks to our Executive Producer Nick Opich and Program Director Shea Gunther at Marijuana Today

You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:

Twitter: @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/

Facebook: https://www.facebook.com/TheGreenRushPodcast/

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Kashif Shan, CEO and Founder of Folium Biosciences

Kashif Shan, CEO and founder of Folium Biosciences, the largest vertically integrated producer, manufacturer and distributor of hemp-derived phytocannabinoinds, is this week’s guest on the Green Rush!

With the passage of the Farm Bill in 2018, hemp and CBD is now 100% legal so Anne and Lewis sat down with Kashif to get an overview of the current state of the CBD space, the future growth market for hemp derived CBD and when we may see big box retailers take a bigger step into the CBD marketplace. In addition to touching on the overall industry, Kashif provides our listeners an in-depth look at the inception and growth of Folium Biosciences, how the company plans to use the funds it received from a recent investment by Australis Capital, what Folium’s R&D department is working on right now and the story of how Kashif let his conservative parents know he was working in the cannabis industry.

This week’s conversation is sure to be a treat for those who are interested in learning more about the CBD space. So sit back and enjoy!

Kashif Shan is the Founder and CEO of Folium Biosciences. Kashif has spent over 20 years as a High Technology Executive across a range of fields where he oversaw Finance, Facilities, and HR. Kashif founded Folium Biosciences in 2014 and has helped grow the company to become the global leader in non-psychoactive cannabinoids and employs over 250 people. Prior to entering the cannabis space, Kashif was the Founder of Equus Capital, a real estate investment company.

Links to guest’s social media:

Links and Mentions:

Show Credits:

This episode was hosted by Lewis Goldberg and Anne Donohoe of KCSA Strategic Communications.

Special thanks to our Producer Nick Opich and Program Director Shea Gunther at Marijuana Today

You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:

Twitter / Instagram: @KCSA_Cannabis

LinkedIn: https://www.linkedin.com/company/green-rush-comms/

Facebook:https://www.facebook.com/KCSACannabiz/

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

 

Powered by WordPress. Designed by WooThemes